Ensuring the seasonal flu vaccine is ready, safe and effective involves months of international planning, testing and collaboration
Similar Posts
Device specific vigilance guidance: Inferior vena cava (IVC) filters
Guidance for manufacturers of IVC filters. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Clinical trials for medicines: apply for authorisation in the UK
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Five festive mistakes you didn’t know you were making: MHRA urges the public to be merry, not risky – don’t mix medicines with alcohol
This holiday season, the MHRA is highlighting one of the most overlooked winter health risks: combining medicines with alcohol.
Guidance: MORE Registrations – user reference guide
A step-by-step guide on using the MORE Platform for Registrations for Submissions of device related incidents.
Medicines regulator approves up to 7.2mg dose of semaglutide (Wegovy) for patients with obesity only
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 2026.
MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek
The tenth annual #MedSafetyWeek brings together more than 130 medicines regulators and health organisations across 117 countries to encourage people to report suspected side effects from medicines and device incidents.